Literature DB >> 15221302

Eotaxin-1 (CCL11) up-regulation in tears during seasonal allergic conjunctivitis.

Simone Eperon1, Alain Sauty, René Lanz, Annette Leimgruber, Floriana Lurati, Yan Guex-Crosier.   

Abstract

PURPOSE: To compare in-season eotaxin-1 levels in tears of patients suffering from seasonal allergic conjunctivitis (SAC) with (1) tears of normal subjects and (2) tears of SAC patients out of season.
METHODS: Tears of 11 SAC patients and six control volunteers were collected during the pollen season. Tears of five SAC patients showing a strong sensitivity to grass pollen (skin-prick tests and specific serum IgE) were collected both in season and out of season. ELISA measured eotaxin-1 level.
RESULTS: Eotaxin-1 concentration in tears of SAC patients [2,100+/-503 (SEM) pg/ml] and normal subjects (1,193+/-176 pg/ml) were significantly different (P=0.0049). Regarding allergic patients, the clinical score (sum of five allergic criteria) was significantly different in season and out of season (P=0.0043) as was also the case with eotaxin-1 concentration (P=0.024).
CONCLUSIONS: The eotaxin-1 concentration in tears of patients showing hay fever could confirm a diagnosis of seasonal ocular allergy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221302     DOI: 10.1007/s00417-004-0943-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

Review 1.  International union of pharmacology. XXII. Nomenclature for chemokine receptors.

Authors:  P M Murphy; M Baggiolini; I F Charo; C A Hébert; R Horuk; K Matsushima; L H Miller; J J Oppenheim; C A Power
Journal:  Pharmacol Rev       Date:  2000-03       Impact factor: 25.468

2.  Chemokines in the limbal form of vernal keratoconjunctivitis.

Authors:  A M Abu El-Asrar; S Struyf; S A Al-Kharashi; L Missotten; J Van Damme; K Geboes
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

Review 3.  Eotaxin and eosinophil recruitment: implications for human disease.

Authors:  S M Rankin; D M Conroy; T J Williams
Journal:  Mol Med Today       Date:  2000-01

4.  Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3.

Authors:  M Kitaura; T Nakajima; T Imai; S Harada; C Combadiere; H L Tiffany; P M Murphy; O Yoshie
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

5.  Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells.

Authors:  F Sallusto; C R Mackay; A Lanzavecchia
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

Review 6.  The eosinophil and the eye.

Authors:  S Bonini; L Magrini; G Rotiroti; A Lambiase; M Tomassini; C Rumi; S Bonini
Journal:  Allergy       Date:  1997       Impact factor: 13.146

7.  Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis.

Authors:  Andrea Leonardi; Peter J Jose; Hong Zhan; Virginia L Calder
Journal:  Ophthalmology       Date:  2003-03       Impact factor: 12.079

8.  CC-chemokine receptor 3: a possible target in treatment of allergy-related corneal ulcer.

Authors:  Kazumi Fukagawa; Naoko Okada; Hiroshi Fujishima; Toshiharu Nakajima; Kazuo Tsubota; Yoji Takano; Hiroshi Kawasaki; Hirohisa Saito; Koichi Hirai
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-01       Impact factor: 4.799

9.  Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils.

Authors:  P D Ponath; S Qin; D J Ringler; I Clark-Lewis; J Wang; N Kassam; H Smith; X Shi; J A Gonzalo; W Newman; J C Gutierrez-Ramos; C R Mackay
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

Review 10.  The central role of conjunctival mast cells in the pathogenesis of ocular allergy.

Authors:  Andrea Leonardi
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

View more
  4 in total

1.  Relationship between tear eotaxin-2 and MMP-9 with ocular allergy and corneal topography in keratoconus patients.

Authors:  Melek Mutlu; Ozge Sarac; Nurullah Cağıl; Gamze Avcıoğlu
Journal:  Int Ophthalmol       Date:  2019-07-30       Impact factor: 2.031

Review 2.  A Review of Emerging Tear Proteomics Research on the Ocular Surface in Ocular Allergy.

Authors:  Esrin Aydin; Poshmaal Dhar; Moneisha Gokhale; Luke Chong; Serap Azizoglu; Cenk Suphioglu
Journal:  Biology (Basel)       Date:  2022-02-16

3.  Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells.

Authors:  Megan E Cavet; Stepan Volhejn; Karen L Harrington; Jin-Zhong Zhang
Journal:  Mol Vis       Date:  2013-07-19       Impact factor: 2.367

4.  Total IgE and eotaxin (CCL11) contents in tears of patients suffering from seasonal allergic conjunctivitis.

Authors:  Simone Eperon; Marouen Berguiga; Pierluigi Ballabeni; Catherine Guex-Crosier; Yan Guex-Crosier
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-12       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.